Cargando…
Pembrolizumab-related renal toxicities: diagnosis first, treatment later
Checkpoint inhibitors are increasingly used to treat different types of malignancy and have been associated with renal toxicities. In this issue, Izzedine et al. report on the incidence of pembrolizumab-associated renal toxicity in a French single-centre nephrology referral centre. They report an es...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366137/ https://www.ncbi.nlm.nih.gov/pubmed/30746131 http://dx.doi.org/10.1093/ckj/sfy114 |